Sonoma Pharmaceuticals Inc
(SNOA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,457 | -4,835 | -5,151 | -5,086 | -3,950 |
| Depreciation Amortization | 138 | 176 | 125 | 186 | 227 |
| Income taxes - deferred | 357 | -109 | -37 | -829 | N/A |
| Accounts receivable | 434 | -230 | -4 | 1,971 | 2,608 |
| Accounts payable and accrued liabilities | 416 | -278 | -864 | -157 | -796 |
| Other Working Capital | 2,650 | 1,854 | -1,757 | 3,354 | 1,384 |
| Other Operating Activity | -626 | 1,024 | 1,536 | -3,687 | -2,851 |
| Operating Cash Flow | $-88 | $-2,398 | $-6,152 | $-4,248 | $-3,378 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -80 | -2 | -269 | -137 | -179 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 610 |
| Purchase Of Investment | N/A | N/A | 11 | 38 | -43 |
| Investing Cash Flow | $-80 | $-2 | $-258 | $-99 | $388 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 274 | 373 | 515 | 123 | N/A |
| Debt Issued | N/A | N/A | N/A | N/A | 1,310 |
| Debt Repayment | N/A | N/A | -120 | -467 | N/A |
| Common Stock Issued | 3,161 | 1,784 | 2,868 | 7,770 | 2,287 |
| Common Stock Repurchased | -1 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -404 | -481 | -774 | -30 | -289 |
| Financing Cash Flow | $3,030 | $1,676 | $2,489 | $7,396 | $3,308 |
| Exchange Rate Effect | -616 | 32 | 345 | 127 | 211 |
| Beginning Cash Position | 3,128 | 3,820 | 7,396 | 4,220 | 3,691 |
| End Cash Position | 5,374 | 3,128 | 3,820 | 7,396 | 4,220 |
| Net Cash Flow | $2,246 | $-692 | $-3,576 | $3,176 | $529 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88 | -2,398 | -6,152 | -4,248 | -3,378 |
| Capital Expenditure | -80 | -2 | -269 | -137 | -179 |
| Free Cash Flow | -168 | -2,400 | -6,421 | -4,385 | -3,557 |